SANGAMO THERAPEUTICS, INC Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SANGAMO THERAPEUTICS, INC for March 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29 2021 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP, PFO and PAO | Payment of Exercise | F | 12.27 | 345 | 4,233 | 40,790 | 41.1 K to 40.8 K (-0.84 %) |
| Mar 25 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Option Exercise | M | 11.02 | 11,981 | 132,031 | 238,019 | |
| Mar 25 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Sell | S | 13.17 | 543 | 7,152 | 83,238 | 83.8 K to 83.2 K (-0.65 %) |
| Mar 25 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Sell | S | 13.18 | 5,000 | 65,901 | 83,781 | 88.8 K to 83.8 K (-5.63 %) |
| Mar 25 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Sell | S | 13.10 | 11,981 | 156,989 | 88,781 | 100.8 K to 88.8 K (-11.89 %) |
| Mar 25 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Buy | M | 11.02 | 11,981 | 132,031 | 100,762 | 88.8 K to 100.8 K (+13.50 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP Principal Acct. ... | Option Exercise | A | 11.19 | 27,500 | 307,725 | 27,500 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP Principal Acct. ... | Grant | A | 0.00 | 13,750 | 0 | 41,135 | 27.4 K to 41.1 K (+50.21 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP Principal Acct. ... | Payment of Exercise | F | 11.19 | 1,863 | 20,847 | 27,385 | 29.2 K to 27.4 K (-6.37 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Option Exercise | A | 11.19 | 80,000 | 895,200 | 80,000 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Grant | A | 0.00 | 40,000 | 0 | 98,199 | 58.2 K to 98.2 K (+68.73 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Payment of Exercise | F | 11.19 | 7,779 | 87,047 | 58,199 | 66 K to 58.2 K (-11.79 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | McClung David Mark | EVP, Chief Business ... | Option Exercise | A | 11.19 | 80,000 | 895,200 | 80,000 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | McClung David Mark | EVP, Chief Business ... | Grant | A | 0.00 | 40,000 | 0 | 140,000 | 100 K to 140 K (+40.00 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Option Exercise | A | 11.19 | 88,000 | 984,720 | 88,000 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Grant | A | 0.00 | 44,000 | 0 | 88,781 | 44.8 K to 88.8 K (+98.26 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Payment of Exercise | F | 11.19 | 5,762 | 64,477 | 44,781 | 50.5 K to 44.8 K (-11.40 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Option Exercise | A | 11.19 | 276,750 | 3,096,833 | 276,750 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Grant | A | 0.00 | 138,375 | 0 | 347,066 | 208.7 K to 347.1 K (+66.31 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Payment of Exercise | F | 11.19 | 35,311 | 395,130 | 208,691 | 244 K to 208.7 K (-14.47 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 8,200 | 0 | 48,200 | 40 K to 48.2 K (+20.50 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Grant | A | 0.00 | 8,200 | 0 | 25,700 | 17.5 K to 25.7 K (+46.86 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Grant | A | 0.00 | 8,200 | 0 | 23,200 | 15 K to 23.2 K (+54.67 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Grant | A | 0.00 | 8,200 | 0 | 31,200 | 23 K to 31.2 K (+35.65 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Grant | A | 0.00 | 8,200 | 0 | 23,200 | 15 K to 23.2 K (+54.67 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Markels John | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Markels John | Director | Grant | A | 0.00 | 8,200 | 0 | 13,200 | 5 K to 13.2 K (+164.00 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Hillan Kenneth J. | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Hillan Kenneth J. | Director | Grant | A | 0.00 | 8,200 | 0 | 23,200 | 15 K to 23.2 K (+54.67 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Grant | A | 0.00 | 8,200 | 0 | 23,200 | 15 K to 23.2 K (+54.67 %) |